niPGT-A for Infertility (niPGT-A_RCT Trial)

"The purpose of this 12-week clinical study is to analyze an embryo's chromosomes without invasively collecting tissue samples. Additionally, we will be looking at the results of next generation sequencing (NGS) applied to the SBM, informativity rates and prioritization category of the SBM analysis results in relation to embryo development, culture conditions and collection time, as well as the cumulative live birth rate and ongoing pregnancy rate in the 6 months following treatment."

"This study is looking for 1108 participants that have struggled with infertility between the ages of 20 and 40. The most important criteria that applicants should meet are as follows: Patients who have given written informed consent approved by the Ethics Committee (EC), after being made aware of what the study entails and voluntarily deciding to participate., IVF patients intending to undergo deferred day 6/7 blastocyst SET for any medical indication., All the oocytes/embryos from the cycle should follow the laboratory protocol described in the study (embryo culture and vitrification on day 6/7)., ICSI, IVF or ICSI"

"That is correct, the online information indicates that the trial is still recruiting individuals. The first posting was on June 14th, 2019 with the most recent update being December 30th, 2020. There is a goal to enroll 1,108 patients from a single location."

"This particular clinical trial only accepts patients aged 20 through 40 that meet the other listed requirements. In contrast, there are 21 trials for those under 18 and 39 for senior citizens."

"The clinical trial currently posted on clinicaltrials.gov is actively recruiting participants. The study was originally posted on 6/14/2019 and was last updated on 12/30/2020."